NJIT Pandemic Recovery Plan
Research Continuity Plan:
Phased Recovery Operations
Updated November 20, 2020
Current Recovery Phase: Phase-2
Ramp Up Phase-1, Phase-2 and Phase-3 Research Continuity and Recovery Operations Plan
For ramping up the phased research continuity and recovery operations, the following guidelines and protocols should be adopted for restoring research activities. The following protocols are subject to change based on the guidance and regulations from the federal, state, and local government agencies.
Phase-1: The institutionally approved Phase-1 research operations should continue with the required social distancing and safety protocols. As the phased research recovery plans ramp up carefully with a gradual and safe start of laboratory research activities, there will be an overlap of Phase-1 research recovery operations transitioning into the institutional Phase-2 operations. The current Phase-1 research recovery period is recommended until June 30, 2020 subject to the availability of appropriate PPE to enforce required safety protocols. The requested PPE supplies for Phase-1 operations have been ordered though the university but there may be delays in receiving the requested supplies depending on the availability in the market. Research labs are responsible for purchasing appropriate PPE supplies from their own funds in subsequent phases of research operations.
Phase-2: Each department should prepare a ramp up Phase-2 Research Continuity and Recovery (Phase-2 RCR) plan. The Phase-2 RCR plan should be approved by the college dean and then forwarded to the Office of Research for institutional approvals. As Phase-2 recovery would ramp up research activities to most funded research operations, the approvals to additional laboratory research operations would be approved by the department chair following the Phase-2 RCR plan subject to the availability of appropriate PPE to enforce required social distancing and safety protocols (consistent with federal, state and local guidelines).
Phase-3: Each department should prepare a ramp up Phase-3 Research Continuity and Recovery (Phase-3 RCR) plan. The Phase-3 RCR plan should be approved by the college dean and then forwarded to the Office of Research for institutional approvals. As Phase-3 recovery would ramp up research activities to most funded and unfunded research operations, the approvals to additional laboratory research operations would be approved by the department chair following the Phase-3 RCR plan subject to the availability of appropriate PPE to enforce required social distancing and safety protocols (consistent with federal, state and local guidelines).
Templates for recommended Phase-2 Research Operation (PRO-2) approval form, and departmental Phase-2 and Phase-3 Research Continuity and Receiver (RCR) plans are posted on the research website
NJIT Phased Research Recovery Plan
NJIT faculty, staff, and students at research facilities must follow the specific social distancing and safety protocols including the use of personnel protective equipment (PPE) as required by the institutional, state and federal guidelines in the respective phase of the research continuity plan. State and national information regarding current conditions can be found at:
- New Jersey’s COVID-19 information hub: https://covid19.nj.gov/index.html
- White House Plan for Opening up America Again: https://www.whitehouse.gov/wp-content/uploads/2020/04/Guidelines-for-Opening-Up-America-Again.pdf
- CDC guidelines on “Symptoms of Coronavirus”: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
- CDC guidelines on “Use of Cloth Face Coverings to Help Slow the Spread of COVID-19”: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/diy-cloth-face-coverings.html
The following guidelines should be adapted with each respective phase for the recovery of research operations.
Recovery Phase-0: All non-essential research operations halted. Essential research operations follow strictest social distancing and safety protocols with only essential staff.
- Safety within laboratories must be rigorously maintained with adequate access to PPE and other safety related supplies. Labs will not be authorized for access unless adequate safety supplies are identified as being available. PIs must identify by name the people that will be considered essential personnel (including replacements/backups). During this time all essential research operations (ERO) must be approved by chair, dean, and the senior vice provost for research through the emergency research continuity plan process currently in place.
- Research involving human subjects that requires face-to-face interaction with human subjects is halted.
- Research that can be conducted remotely should be continued to the extent possible.
Recovery Phase-1: Minimal research operations approved through chairs, deans and senior vice provost for research to pursue time-sensitive priority research such as projects related to COVID-19 response; approved Essential Research Operation (ERO) plans in Phase-0; long-term research experiments with cell-lines, animals, and human subjects that were already underway before Phase-0; grants and contracts expiring within six months; submission of proposals in response to special solicitations (Requests for Proposals); and projects involving students with graduation requirements.
- Requests for projects considered time-sensitive should be directed to departmental chairs. The dean and senior vice provost for research will provide guidance as needed.
- All research operations at NJIT facilities in this phase must follow the highest possible level of social distancing implemented.
- Research that can be conducted remotely should be continued to the extent possible.
- As on-campus operations are limited following the state and institutional safety regulations, visiting access to on-campus facilities is restricted.
- New applications for visiting scholars for research are on hold until NJIT enters the “new normal” phase of recovery.
Recovery Phase-2: Most research operations, whether sponsored through external grants and contracts or internally funded, may be restarted through the approval of department chairs using significant social distancing and safety protocols with restrictions on the number of researchers and staff present in laboratories at one time.
- The Phase-2 restart may require developing flexible work schedules, plan for supply chain issues, and prepare core and fabrication facilities in advance of need. To ensure social distancing requirements and to reduce density of research personnel in university research spaces, the lab directors should consider permitting flexible lab access schedules, work shifts or staggered workdays, and extended facilities support to enable more round-the-clock operation of research facilities. Under no circumstances should safety be sacrificed due to lack of adequate supplies, type, and quality of PPE.
- Research that can be conducted completely remotely or in addition to the on-campus operations should continue to be conducted in that manner.
- As on-campus operations are limited following the state and institutional safety regulations, visiting access to on-campus facilities is restricted.
- New applications for visiting scholars for research are on hold until NJIT enters the “new normal” phase of recovery.
Recovery Phase-3: Most research operations on funded and unfunded projects along with research required for future proposal submissions are restored with minimal social distancing and personnel safety protocols.
- Group meetings and research presentations with faculty, staff and students should be restricted and kept to a minimal size protecting any vulnerable participants. If possible, these meetings should continue to be held online until we reach a state of full recovery.
- Other laboratory safety protocols must be strictly followed.
- Research that can be conducted completely remotely or in addition to the on-campus operations should continue to be conducted in that manner.
- New applications for visiting scholars for research are on hold until NJIT enters the “new normal” phase of recovery.
Full Recovery: All research operations are restored fully with no specific social distancing requirements. However, all laboratory and personnel safety protocols must be strictly followed.
This document refers to research conducted on the NJIT campus in Newark, NJ, including the physical campus and activities that have direct contact with individuals (human subjects) anywhere. Satellite locations, such as the Big Bear Solar Observatory in California, must follow a similar phased approach informed by local conditions.
NJIT Research Continuity Plan: Phase-0
Updated March 26, 2020
Due to rapidly growing COVID-19 Pandemic, Governor Murphy has issued stay-at-home orders effective 9.00 PM, March 21, 2020.
All non-essential research operations in NJIT research laboratories and facilities are halted temporarily until further notice for the safety of the community and to be in compliance with the state order and associated travel restrictions. Limited continuation of laboratory research is only permitted for essential research operations but must follow the strongest safety protocols including the social distancing while working in the lab.
Essential research operations that are critical to maintenance and monitoring of research facility, animal care (with approved contingency plan) or exceptional experiments for which termination will lead to the irreversible loss of data must be approved at the institutional level (https://research.njit.edu/research-continuity-plan)
Students and post-docs must not be asked or expected to travel to campus for any non-essential research activity for their safety and to be in compliance with state and institutional regulations with the stay at home order.
As requested earlier, the checklist (posted on the research website (https://research.njit.edu/research-continuity-plan) should be followed to shut-down research laboratory operations.
All research activities that can be pursued remotely should be continued.
We hope that this period of unprecedented disruption will be over shortly. Until then please take every precaution to be safe and healthy.
Research Administration and Compliance
The Office of Research will continue to provide assistance on proposal submissions, pre-award and post-award grant management, research compliance and operational protocols to the best of our abilities. It is expected that Streamlyne will remain operational for proposal submissions and the following email addresses will be monitored regularly:
- Pre-Award inquiries: srard@njit.edu
- Post-Award financial management: gca@njit.edu
- Institutional Review Board: irb@njit.edu
- Institutional Biosafety Committee: ibc@njit.edu
Updates and university-wide resources in response to COVID-19 outbreaks are posted on the NJIT website https://www.njit.edu/coronavirus
If you have any questions related to research, please contact the Office of Research.
Coronavirus (COVID-19) Information on Sponsored Research Grants and Contracts
(Updated May 3, 2020)
Guidance on Financial Management of Grants and Contracts
The Office of Management and Budget issued a memorandum on 19 March 2020 (OMB 20-17 https://www.whitehouse.gov/wp-content/uploads/2020/03/M-20-17.pdf) providing guidance on issues related to grant management during the COVID-19 disruption. This memorandum provides short term relief for administrative, financial management, and audit requirements under 2 CFR Part 200, Uniform Administrative Requirements, Cost principles and Audit Requirements for Federal Awards, for the management of grants and contracts from all federal and non-federal sources under the COVID-19 public health emergency without compromising federal financial assistance accountability requirements.
Funding agencies such as NSF and NIH are following the OMB guidance with respect to grant management during this disruption to university business and research. The OMB Memorandum M-20-17 with the important information on the financial management of the research grants and contracts is posted on the research website https://research.njit.edu/research-continuity-plan. Links to current notifications from federal agencies are provided below. Principal investigators should check with the websites of their specific funding agencies for more information.
COVID-19 Information for NSF applicants and award recipients FAQ is regularly updated on the website https://www.nsf.gov/bfa/dias/policy/covid19/covid19faqs_dcl.pdf. COVID-19 Information for NIH applicants and recipients of NIH funding is regularly updated on the website https://grants.nih.gov/policy/natural-disasters/corona-virus.htm. A multiple Funding Agencies Research Impact Guidance Matrix by the Council of Government Relationships is posted on the website COGR's Federal Agency Guidance Matrix (XLS)
Coronavirus (COVID-19) Information on Sponsored Research Impact
Updated May 17, 2020
The Office of Research will continue to compile links for agency-specific guidance. The updates will be included in forthcoming Office of Research Newsletters and also posted on website https://research.njit.edu/.
Council on Government Relationships Resources on COVID-19's Impact to Federal Awards
- COGR Resource Information Institutional and Agency Responses to COVID-19 and Additional Resources (Updated Regularly)
- COGR's Federal Agency Guidance Matrix (XLS) (Updated) (Revised May 14, 2020)
- FAQ Addendum #1: NIH Specific FAQs (Updated) (Revised June 12, 2020)
- FAQ Addendum #2: Costing and Financial Compliance FAQs (Updated) (Revised May 1, 2020)
- FAQ Addendum #3: Research Ethics and Compliance Human Subjects FAQ (Version 1.0) (Revised May 4, 2020)
- FAQ Addendum #4: Contracts and Grants Administration FAQs (Version 1.0) (Revised May 8, 2020)
- FAQs Regarding COVID-19's Impact to Federal Awards (V.2.2) (Revised April 8, 2020)
- Multi Association Request to OMB on Expansion of M-20-11 for Administrative Relief (Revised March 18, 2020)
Office of Management and Budget
- M-20-20: Repurposing Existing Federal Financial Assistance Programs and Awards to Support the Emergency Response to the Novel Coronavirus (COVID-19) (April 9, 2020)
- M-20-18: Managing Federal Contract Performance Issues Associated with the Novel Coronavirus (COVID-19) (March 20,2020)
- OMB M-20-17: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (March 19, 2020)
- M-20-11: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) (March 9, 2020)
National Institutes of Health (NIH)
Information on research impact:
- https://www.nih.gov/health-information/coronavirus
- https://grants.nih.gov/grants/natural_disasters/corona-virus.htm
On grant management:
- https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-083.html
- https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-082.html (Application deadlines)
- https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-091.html (Late application policy)
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients
- FAQ – COVID-19 Flexibilities for Applicants and Recipients
- Extramural Response to Natural Disasters and Other Emergencies (continuously updated)
- General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19 (NOT-OD-20-083)
- Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 (NOT-OD-20-087)
- Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19 (NOT-OD-20-088)
- Guidance on Travel and Meetings Hosted by NIH
- OLAW Webinar: Pandemic Contingency Planning and Its Impact on Animal Care
- NIH Shifts Non-mission-critical Laboratory Operations to Minimal Maintenance Phase
- Research and Funding Opportunities
- NIH Message to Applicants and Recipients of NIH Funds on Flexibilities Needed for COVID-19 (video)
- National Library of Medicine Expands Access to COVID-19 Literature through PubMed Central
- Late Application Policy Due to Public Health Emergency for US Due To COVID-19 (NOT-OD-20-091)
- Updated on COVID-19 Flexibilities for the Research Community (video)
National Science Foundation (NSF)
- NSF Implementation of OMB Memorandum M-20-20 (April 10, 2020)
- Frequently Asked Questions (FAQs) regarding the NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (NSF 20-052) (Updated 4/6/20)
- NSF Implementation of OMB Memorandum M-20-17 (Revised April 1, 2020)
- https://www.nsf.gov/bfa/dias/policy/covid19/
covid19faqs_proposerandawardee.pdf (Revised April 2, 2020) - Impact on Existing Deadline Dates
- FAQ About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees
- Important Notice No. 146 - NSF Letter to Community Regarding COVID-19
- NSF Guidance for Major Facilities and Contracts Regarding COVID-19
- NSF Responses to Natural Disasters
- Coronavirus Information
- Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Panelists
- NSF information concerning coronavirus disease 2019 (COVID-19)
- Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
- BIO-Wide Virtual Office Hours
NSF Research on Coronavirus (COVID-19)
- Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) — RAPID
- Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) — RAPID
- Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19
- NSF Supporting Research to Address Coronavirus Disease blog
US Department of Energy
- ARPA-E Actions Owing to the COVID-19 Public Health Emergency (April 3, 2020)
- Accommodating Interruptions from Coronavirus Disease 2019 (COVID-19)
- Department of Energy Letter Addressing Coronavirus (COVID-19)
- Coronavirus Hub
United States Army Medical Research Acquisition Activity (USAMRAA)
- USAMRAA’s Supplemental Guidance on Administrative Flexibilities for Grants and Cooperative Agreements in Response to COVID-19 Pandemic (3/25/20)
- USAMRAA Animal Research Guidance (3/19/20)
- FAQs on COVID-19's Impact to Human Subjects Research
Defense Advanced Research Projects Agency (DARPA)
- COVID-19 Guidance USD(R&E)
- Frequently Asked Question (FAQ) about COVID-19 (Coronavirus) for DARPA Performers (March 19)
Department of Defense (DOD)
- ALLOW EXEMPTIONS FOR DOD FINANCIAL ASSISTANCE RECIPIENTS AFFECTED BY THE LOSS OF OPERATIONAL CAPACITY AND INCREASED COSTS DUE TO THE
COVID-19 CRISIS - COVID-19 FAQs for Grant Applicants and Recipients (3/26/20)
- Frequently Asked Questions for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19) (3/24/20)
National Air and Space Administration (NASA)
- NASA COVID -19 For Grantees
- NASA Implementation of OMB Memorandum M-20-17 (Undated)
- Grants and Research during the COVID-19 Epidemic (3/25/20)
- COVID-19 Impact to NASA SBIR/STTR Program
- Coronavirus Information
- Assistant Administrator for Procurement Message on Coronavirus
- Memorandum for NASA Contractor Community - Preserving Readiness of the Space Industrial Base and Mission Operational Readiness due to COVID-19
USDA - National Institute of Food and Agriculture
- NIFA-20-006 Implementation of OMB Memo M-20-17 (4/9/20)
- NIFA FAQS for Grantees (4/8/20)
- NIFA Deadline Extensions due to COVID-19 (3/18.20)
- FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
- FAQs on 3D Printing of Medical Devices, Accessories, Components, and Parts During the COVID-19 Pandemic
- FDA - Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 (3/26/20)
Department of Health and Human Services
- OHRP Issues Guidance for Application of the Human Subjects Protection Regulations to Actions Taken in Response to the COVID-19 Pandemic (4/9/20)
- Preparation for Potential COVID-19 Impact on Contract and Contractor Performance (3/14/20)
- Administration for Children and Families (ACF) Grantees and Recipients- Information Memorandum: IM-ACF-OA-2020-01 (3/31/20)
- ORI Operations Status during Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
Environmental Protection Agency
National Endowment for the Arts (NEA)
National Endowment for the Humanities (NEH)
Related Links:
- NJIT Essential Research Operation Approval Form
- Guidelines and Protocols of Multi-Phased Research Continuity and Recovery Plan
- Template NJIT Phase-2 Research Operation Approval Request Form
- Template Phase-2 Department Research Operation Plan
- Phased Research Recovery Plan PPT Diagram V1 06-11-2020
- Phase-1 Research Operations (PRO-1) Approval Request Form
- Phase-1 Research Operations - Personnel Logbook
- Research Continuity Plan: Guidance on Research Grant Management: April 12, 2020
- COVID-19 Funding Agencies Guidance Matrix: April 8, 2020
- Research Continuity Plan: March 26, 2020
- Research Continuity Plan: March 17, 2020
- Research Continuity Plan: March 16, 2020
- NJIT Checklist for Ramping Down Research Laboratory Operations